Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alkermes (ALKS) EBIT (2016 - 2026)

Alkermes has reported EBIT over the past 16 years, most recently at -$159.4 million for Q4 2025.

  • Quarterly EBIT rose 21.27% to -$159.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.4 million through Dec 2025, down 34.32% year-over-year, with the annual reading at $36.4 million for FY2025, 34.32% down from the prior year.
  • EBIT was -$159.4 million for Q4 2025 at Alkermes, down from $89.1 million in the prior quarter.
  • Over five years, EBIT peaked at $281.3 million in Q2 2023 and troughed at -$202.5 million in Q4 2024.
  • The 5-year median for EBIT is $28.6 million (2024), against an average of $30.0 million.
  • Year-over-year, EBIT plummeted 879.39% in 2022 and then soared 916.29% in 2023.
  • A 5-year view of EBIT shows it stood at $129.4 million in 2021, then dropped by 8.98% to $117.8 million in 2022, then plummeted by 53.62% to $54.6 million in 2023, then crashed by 470.63% to -$202.5 million in 2024, then grew by 21.27% to -$159.4 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's EBIT are -$159.4 million (Q4 2025), $89.1 million (Q3 2025), and $93.0 million (Q2 2025).